From January 1, 2023 to March 31, 2023, the company has repurchased 309,012 shares, representing 1% for $0.48 million. With this, the company has completed the repurchase of 4,190,670 shares, representing 12.61% for $14.7 million under the buyback announced on March 15, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.14 USD | +1.79% | -6.56% | -14.29% |
May. 13 | HC Wainwright Adjusts Price Target on Co-Diagnostics to $2 From $2.50, Maintains Neutral Rating | MT |
May. 09 | Transcript : Co-Diagnostics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.29% | 35.01M | |
-40.31% | 3.01B | |
+18.54% | 1.94B | |
-2.22% | 1.66B | |
+34.26% | 1.34B | |
-16.73% | 965M | |
-22.64% | 895M | |
+7.22% | 827M | |
-25.66% | 638M | |
+8.49% | 516M |
- Stock Market
- Equities
- CODX Stock
- News Co-Diagnostics, Inc.
- Tranche Update on Co-Diagnostics, Inc.'s Equity Buyback Plan announced on March 15, 2022.